In its feedback, the FDA acknowledged the potential breast cancer risk associated with T use in women—a central safety issue that has historically limited the development of a T therapy for women.

While some studies suggest low dose testosterone can be helpful for women, especially during menopause, more research is needed to determine its safety and effectiveness. In females, testosterone is ...

There is no F.D.A.-approved testosterone product for women. Insurance won’t cover it. Many doctors won’t prescribe it. It’s become a cultural phenomenon. Credit... Supported by By Susan Dominus Spend ...

People often feel confused or concerned when they first hear about Klinefelter syndrome and gynecomastia. The post ...